SBI Holdings, Inc. (8473.T)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Yoshitaka Kitao | Chairman of the Board, President & CEO | 301M | -- | 1951 |
Mr. Masato Takamura | Senior EVP, COO, Senior Head of Financial Services Business & Representative Director | 184M | -- | 1969 |
Mr. Tomoya Asakura | Senior Executive VP & Director | 117M | -- | 1966 |
Mr. Hideyuki Katsuchi | CFO & Managing Executive Officer | -- | -- | -- |
Mr. Shumpei Morita | Senior MD, SEVP, Senior Head of Accounting, Finance & Digital Asset Business and Director | 101M | -- | 1974 |
Mr. Masayuki Yamada | GM of Legal & Compliance Dept. and Director | -- | -- | 1962 |
Mr. Motoaki Shiino | GM of Corporate Communication Department & Director | -- | -- | 1974 |
Ms. Satoe Kusakabe | MD & Director | -- | -- | 1970 |
SBI Holdings, Inc.
- Sector:
- Financial Services
- Industry: Financial Conglomerates
- Full Time Employees:
- 19,097
Description
SBI Holdings, Inc. engages in the online securities and investment businesses in Japn and Saudi Arabia. It operates through five business segments: Financial Services Business, Asset Management Business, Investment Business, Crypto-Asset Business, and Non-financial Business segments. The Financial Services Business segment consists of a range of finance-related business, including securities brokerage business; banking services business; and life, property, and casualty insurance business. The Asset Management Business segment includes setting, solicitation, and management of investment trust; investment advice; and financial products information. The Investment Business segment includes fund management and investment in Internet technology, fintech, blockchain, finance, and biotechnology-related venture companies; private equity; and funds management businesses. The Crypto-asset Business segment provides crypto-asset exchange and trading services. The Non-Financial Business segment consists of biotechnology; development and distribution of pharmaceutical products, health foods, and cosmetics with 5-aminolevulinic acid; research and development of antibody drugs and nucleic acid medicine in the field of cancer and immunology; the digitization of medical and health information; provision of solutions and services that promote the use of medical big data, medical finance; business working on advanced fields related to Web 3.0; and renewable energy business. The company is also involved in the real estate secured loans, online mobile game, and e-sports related businesses. In addition, it operates and develops cybersecurity systems; exports used cars; offers back-office support services; and develops, operates, manages, and invests in real estate properties. The company was formerly known as Softbank Investment Corporation and changed its name to SBI Holdings, Inc. in July 2005. SBI Holdings, Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan.
Corporate Governance
Upcoming Events
May 9, 2025 at 2:00 AM UTC
SBI Holdings, Inc. Earnings Date
Recent Events
September 27, 2024 at 12:00 AM UTC
Ex-Dividend Date